Mice lacking Nppa developed cardiomyocyte hypertrophy [72,73], hence the decreased expression of NPPA we detected in diseased hearts of CTEPH patients might represent a potential mechanism for hypertrophy. Here, NPPA is linked to chronic thromboembolic pulmonary hypertension.